Leading oncology group wary of Trump drug price proposals

by reuter.com
https://ift.tt/pnED7n
CHICAGO (Reuters) - America's leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs, warning that patients must not be barred from medicines that could help them.

Read more

Share on Facebook Share on Twitter Share on Google Plus

About New

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.